Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

A high risk high reward Finnish AI-stock, but not for your grandmothers portfolio

By Antti LuiroHead of Nordic ER Development, Analyst
Aiforia Technologies

Aiforia is a software company at a commercially early stage whose products enable AI-based image analysis in medicine. The software's primary application is in pathology, where it helps pathologists analyze tissue samples taken from patients. Analyst Antti Luiro comments.

Read the extensive report here https://www.inderes.se/research/aiforia-promisingly-started-growth-journey-just-beginning

Follow Aiforia https://www.inderes.se/companies/Aiforia-Technologies

00:00 Intro
00:27 The big problem Aiforia tries to solve
02:45 How does Aiforia make money?
04:10 Market potential
10:50 Business stickiness
13:35 Dilution risk
16:00 Investment case

Recent videos

Surgical Science Sweden, Capital Markets Day, CMD, 2025
2025-12-08 14:00 Surgical Science Sweden
GreenMobility: What is the investment case in driverless cars
2025-12-05 08:00 GreenMobility
UPM and Sappi are planning a joint venture in graphic papers
2025-12-04 13:00 UPM-Kymmene
GreenMobility: How far away are driverless cars in Denmark
2025-12-04 11:32 GreenMobility
Systemair, Audiocast, Q2'25/26
2025-12-04 09:00 Systemair
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.